ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
The NELSON Trial Reports Large Survival Advantage for Lung Cancer Screening in Europe
Tuesday, September 25, 2018
Submitted by
Source
Source Name: International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer
Source URL: https://www.youtube.com/watch?v=LwOP2cTfHyU
A seismic shift occurred today when the NELSON screening trial results were presented at the IASLC 19th World Conference on Lung Cancer (#WCLC2018). Hear from the CEO, Dr. Fred R. Hirsch, as he comments on these results. Men have a 24% survival advantage in the screening programme. This is a very large shift to earlier stage cancer detection. There can be no doubt that lung cancer screening is a lifesaving intervention in lung cancer.
Printer-friendly
